Multiparametric In-vitro Cardiotoxicity Testing Market, Global Outlook and Forecast 2023-2029

Report ID: MMG260381 | Category: Service & Software | Pages: 68 | Format: PDF | Published Date: November 01,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

The global Multiparametric In-vitro Cardiotoxicity Testing market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Calcium Transient Assay Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Multiparametric In-vitro Cardiotoxicity Testing include Creative Bioarray, Agilent Technologies, Inc., Hemogenix Inc., Merck KGaA, Molecular Devices, LLC., Miltenyi Biotec, FUJIFILM Cellular Dynamics, Enzo Life Sciences, Inc. and Axol Bioscience Ltd., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Multiparametric In-vitro Cardiotoxicity Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Multiparametric In-vitro Cardiotoxicity Testing. This report contains market size and forecasts of Multiparametric In-vitro Cardiotoxicity Testing in global, including the following market information:
Global Multiparametric In-vitro Cardiotoxicity Testing Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Multiparametric In-vitro Cardiotoxicity Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Multiparametric In-vitro Cardiotoxicity Testing Market, by Type of Assay, 2018-2023, 2024-2029 ($ millions)
Global Multiparametric In-vitro Cardiotoxicity Testing Market Segment Percentages, by Type of Assay, 2022 (%)
    Calcium Transient Assay
    Cardiac Marker Detection
    hERG Assay
    Multi-ion Channel Assay
    Others
Global Multiparametric In-vitro Cardiotoxicity Testing Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Multiparametric In-vitro Cardiotoxicity Testing Market Segment Percentages, by Application, 2022 (%)
    Contract Research Organizations (CROs)
    Pharmaceutical and Biotech Companies
    Others
Global Multiparametric In-vitro Cardiotoxicity Testing Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Multiparametric In-vitro Cardiotoxicity Testing Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Multiparametric In-vitro Cardiotoxicity Testing revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Multiparametric In-vitro Cardiotoxicity Testing revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Creative Bioarray
    Agilent Technologies, Inc.
    Hemogenix Inc.
    Merck KGaA
    Molecular Devices, LLC.
    Miltenyi Biotec
    FUJIFILM Cellular Dynamics
    Enzo Life Sciences, Inc.
    Axol Bioscience Ltd.
    emka TECHNOLOGIES
    Eurofins Discovery
    Stemina Biomarker Discovery, Inc.
    Evotec
Outline of Major Chapters:
Chapter 1: Introduces the definition of Multiparametric In-vitro Cardiotoxicity Testing, market overview.
Chapter 2: Global Multiparametric In-vitro Cardiotoxicity Testing market size in revenue.
Chapter 3: Detailed analysis of Multiparametric In-vitro Cardiotoxicity Testing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type of assay, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Multiparametric In-vitro Cardiotoxicity Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Multiparametric In-vitro Cardiotoxicity Testing Market Definition
    1.2 Market Segments
        1.2.1 Market by Type of Assay
        1.2.2 Market by Application
    1.3 Global Multiparametric In-vitro Cardiotoxicity Testing Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Multiparametric In-vitro Cardiotoxicity Testing Overall Market Size
    2.1 Global Multiparametric In-vitro Cardiotoxicity Testing Market Size: 2022 VS 2029
    2.2 Global Multiparametric In-vitro Cardiotoxicity Testing Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Multiparametric In-vitro Cardiotoxicity Testing Players in Global Market
    3.2 Top Global Multiparametric In-vitro Cardiotoxicity Testing Companies Ranked by Revenue
    3.3 Global Multiparametric In-vitro Cardiotoxicity Testing Revenue by Companies
    3.4 Top 3 and Top 5 Multiparametric In-vitro Cardiotoxicity Testing Companies in Global Market, by Revenue in 2022
    3.5 Global Companies Multiparametric In-vitro Cardiotoxicity Testing Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Multiparametric In-vitro Cardiotoxicity Testing Players in Global Market
        3.6.1 List of Global Tier 1 Multiparametric In-vitro Cardiotoxicity Testing Companies
        3.6.2 List of Global Tier 2 and Tier 3 Multiparametric In-vitro Cardiotoxicity Testing Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type of Assay - Global Multiparametric In-vitro Cardiotoxicity Testing Market Size Markets, 2022 & 2029
        4.1.2 Calcium Transient Assay
        4.1.3 Cardiac Marker Detection
        4.1.4 hERG Assay
        4.1.5 Multi-ion Channel Assay
        4.1.6 Others
    4.2 By Type of Assay - Global Multiparametric In-vitro Cardiotoxicity Testing Revenue & Forecasts
        4.2.1 By Type of Assay - Global Multiparametric In-vitro Cardiotoxicity Testing Revenue, 2018-2023
        4.2.2 By Type of Assay - Global Multiparametric In-vitro Cardiotoxicity Testing Revenue, 2024-2029
        4.2.3 By Type of Assay - Global Multiparametric In-vitro Cardiotoxicity Testing Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Multiparametric In-vitro Cardiotoxicity Testing Market Size, 2022 & 2029
        5.1.2 Contract Research Organizations (CROs)
        5.1.3 Pharmaceutical and Biotech Companies
        5.1.4 Others
    5.2 By Application - Global Multiparametric In-vitro Cardiotoxicity Testing Revenue & Forecasts
        5.2.1 By Application - Global Multiparametric In-vitro Cardiotoxicity Testing Revenue, 2018-2023
        5.2.2 By Application - Global Multiparametric In-vitro Cardiotoxicity Testing Revenue, 2024-2029
        5.2.3 By Application - Global Multiparametric In-vitro Cardiotoxicity Testing Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global Multiparametric In-vitro Cardiotoxicity Testing Market Size, 2022 & 2029
    6.2 By Region - Global Multiparametric In-vitro Cardiotoxicity Testing Revenue & Forecasts
        6.2.1 By Region - Global Multiparametric In-vitro Cardiotoxicity Testing Revenue, 2018-2023
        6.2.2 By Region - Global Multiparametric In-vitro Cardiotoxicity Testing Revenue, 2024-2029
        6.2.3 By Region - Global Multiparametric In-vitro Cardiotoxicity Testing Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America Multiparametric In-vitro Cardiotoxicity Testing Revenue, 2018-2029
        6.3.2 US Multiparametric In-vitro Cardiotoxicity Testing Market Size, 2018-2029
        6.3.3 Canada Multiparametric In-vitro Cardiotoxicity Testing Market Size, 2018-2029
        6.3.4 Mexico Multiparametric In-vitro Cardiotoxicity Testing Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe Multiparametric In-vitro Cardiotoxicity Testing Revenue, 2018-2029
        6.4.2 Germany Multiparametric In-vitro Cardiotoxicity Testing Market Size, 2018-2029
        6.4.3 France Multiparametric In-vitro Cardiotoxicity Testing Market Size, 2018-2029
        6.4.4 U.K. Multiparametric In-vitro Cardiotoxicity Testing Market Size, 2018-2029
        6.4.5 Italy Multiparametric In-vitro Cardiotoxicity Testing Market Size, 2018-2029
        6.4.6 Russia Multiparametric In-vitro Cardiotoxicity Testing Market Size, 2018-2029
        6.4.7 Nordic Countries Multiparametric In-vitro Cardiotoxicity Testing Market Size, 2018-2029
        6.4.8 Benelux Multiparametric In-vitro Cardiotoxicity Testing Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia Multiparametric In-vitro Cardiotoxicity Testing Revenue, 2018-2029
        6.5.2 China Multiparametric In-vitro Cardiotoxicity Testing Market Size, 2018-2029
        6.5.3 Japan Multiparametric In-vitro Cardiotoxicity Testing Market Size, 2018-2029
        6.5.4 South Korea Multiparametric In-vitro Cardiotoxicity Testing Market Size, 2018-2029
        6.5.5 Southeast Asia Multiparametric In-vitro Cardiotoxicity Testing Market Size, 2018-2029
        6.5.6 India Multiparametric In-vitro Cardiotoxicity Testing Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America Multiparametric In-vitro Cardiotoxicity Testing Revenue, 2018-2029
        6.6.2 Brazil Multiparametric In-vitro Cardiotoxicity Testing Market Size, 2018-2029
        6.6.3 Argentina Multiparametric In-vitro Cardiotoxicity Testing Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Multiparametric In-vitro Cardiotoxicity Testing Revenue, 2018-2029
        6.7.2 Turkey Multiparametric In-vitro Cardiotoxicity Testing Market Size, 2018-2029
        6.7.3 Israel Multiparametric In-vitro Cardiotoxicity Testing Market Size, 2018-2029
        6.7.4 Saudi Arabia Multiparametric In-vitro Cardiotoxicity Testing Market Size, 2018-2029
        6.7.5 UAE Multiparametric In-vitro Cardiotoxicity Testing Market Size, 2018-2029
7 Multiparametric In-vitro Cardiotoxicity Testing Companies Profiles
    7.1 Creative Bioarray
        7.1.1 Creative Bioarray Company Summary
        7.1.2 Creative Bioarray Business Overview
        7.1.3 Creative Bioarray Multiparametric In-vitro Cardiotoxicity Testing Major Product Offerings
        7.1.4 Creative Bioarray Multiparametric In-vitro Cardiotoxicity Testing Revenue in Global Market (2018-2023)
        7.1.5 Creative Bioarray Key News & Latest Developments
    7.2 Agilent Technologies, Inc.
        7.2.1 Agilent Technologies, Inc. Company Summary
        7.2.2 Agilent Technologies, Inc. Business Overview
        7.2.3 Agilent Technologies, Inc. Multiparametric In-vitro Cardiotoxicity Testing Major Product Offerings
        7.2.4 Agilent Technologies, Inc. Multiparametric In-vitro Cardiotoxicity Testing Revenue in Global Market (2018-2023)
        7.2.5 Agilent Technologies, Inc. Key News & Latest Developments
    7.3 Hemogenix Inc.
        7.3.1 Hemogenix Inc. Company Summary
        7.3.2 Hemogenix Inc. Business Overview
        7.3.3 Hemogenix Inc. Multiparametric In-vitro Cardiotoxicity Testing Major Product Offerings
        7.3.4 Hemogenix Inc. Multiparametric In-vitro Cardiotoxicity Testing Revenue in Global Market (2018-2023)
        7.3.5 Hemogenix Inc. Key News & Latest Developments
    7.4 Merck KGaA
        7.4.1 Merck KGaA Company Summary
        7.4.2 Merck KGaA Business Overview
        7.4.3 Merck KGaA Multiparametric In-vitro Cardiotoxicity Testing Major Product Offerings
        7.4.4 Merck KGaA Multiparametric In-vitro Cardiotoxicity Testing Revenue in Global Market (2018-2023)
        7.4.5 Merck KGaA Key News & Latest Developments
    7.5 Molecular Devices, LLC.
        7.5.1 Molecular Devices, LLC. Company Summary
        7.5.2 Molecular Devices, LLC. Business Overview
        7.5.3 Molecular Devices, LLC. Multiparametric In-vitro Cardiotoxicity Testing Major Product Offerings
        7.5.4 Molecular Devices, LLC. Multiparametric In-vitro Cardiotoxicity Testing Revenue in Global Market (2018-2023)
        7.5.5 Molecular Devices, LLC. Key News & Latest Developments
    7.6 Miltenyi Biotec
        7.6.1 Miltenyi Biotec Company Summary
        7.6.2 Miltenyi Biotec Business Overview
        7.6.3 Miltenyi Biotec Multiparametric In-vitro Cardiotoxicity Testing Major Product Offerings
        7.6.4 Miltenyi Biotec Multiparametric In-vitro Cardiotoxicity Testing Revenue in Global Market (2018-2023)
        7.6.5 Miltenyi Biotec Key News & Latest Developments
    7.7 FUJIFILM Cellular Dynamics
        7.7.1 FUJIFILM Cellular Dynamics Company Summary
        7.7.2 FUJIFILM Cellular Dynamics Business Overview
        7.7.3 FUJIFILM Cellular Dynamics Multiparametric In-vitro Cardiotoxicity Testing Major Product Offerings
        7.7.4 FUJIFILM Cellular Dynamics Multiparametric In-vitro Cardiotoxicity Testing Revenue in Global Market (2018-2023)
        7.7.5 FUJIFILM Cellular Dynamics Key News & Latest Developments
    7.8 Enzo Life Sciences, Inc.
        7.8.1 Enzo Life Sciences, Inc. Company Summary
        7.8.2 Enzo Life Sciences, Inc. Business Overview
        7.8.3 Enzo Life Sciences, Inc. Multiparametric In-vitro Cardiotoxicity Testing Major Product Offerings
        7.8.4 Enzo Life Sciences, Inc. Multiparametric In-vitro Cardiotoxicity Testing Revenue in Global Market (2018-2023)
        7.8.5 Enzo Life Sciences, Inc. Key News & Latest Developments
    7.9 Axol Bioscience Ltd.
        7.9.1 Axol Bioscience Ltd. Company Summary
        7.9.2 Axol Bioscience Ltd. Business Overview
        7.9.3 Axol Bioscience Ltd. Multiparametric In-vitro Cardiotoxicity Testing Major Product Offerings
        7.9.4 Axol Bioscience Ltd. Multiparametric In-vitro Cardiotoxicity Testing Revenue in Global Market (2018-2023)
        7.9.5 Axol Bioscience Ltd. Key News & Latest Developments
    7.10 emka TECHNOLOGIES
        7.10.1 emka TECHNOLOGIES Company Summary
        7.10.2 emka TECHNOLOGIES Business Overview
        7.10.3 emka TECHNOLOGIES Multiparametric In-vitro Cardiotoxicity Testing Major Product Offerings
        7.10.4 emka TECHNOLOGIES Multiparametric In-vitro Cardiotoxicity Testing Revenue in Global Market (2018-2023)
        7.10.5 emka TECHNOLOGIES Key News & Latest Developments
    7.11 Eurofins Discovery
        7.11.1 Eurofins Discovery Company Summary
        7.11.2 Eurofins Discovery Business Overview
        7.11.3 Eurofins Discovery Multiparametric In-vitro Cardiotoxicity Testing Major Product Offerings
        7.11.4 Eurofins Discovery Multiparametric In-vitro Cardiotoxicity Testing Revenue in Global Market (2018-2023)
        7.11.5 Eurofins Discovery Key News & Latest Developments
    7.12 Stemina Biomarker Discovery, Inc.
        7.12.1 Stemina Biomarker Discovery, Inc. Company Summary
        7.12.2 Stemina Biomarker Discovery, Inc. Business Overview
        7.12.3 Stemina Biomarker Discovery, Inc. Multiparametric In-vitro Cardiotoxicity Testing Major Product Offerings
        7.12.4 Stemina Biomarker Discovery, Inc. Multiparametric In-vitro Cardiotoxicity Testing Revenue in Global Market (2018-2023)
        7.12.5 Stemina Biomarker Discovery, Inc. Key News & Latest Developments
    7.13 Evotec
        7.13.1 Evotec Company Summary
        7.13.2 Evotec Business Overview
        7.13.3 Evotec Multiparametric In-vitro Cardiotoxicity Testing Major Product Offerings
        7.13.4 Evotec Multiparametric In-vitro Cardiotoxicity Testing Revenue in Global Market (2018-2023)
        7.13.5 Evotec Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Multiparametric In-vitro Cardiotoxicity Testing Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?